Annexon biosciences to participate in the 2023 cantor global healthcare conference

Brisbane, calif., sept. 19, 2023 (globe newswire) -- annexon, inc. (nasdaq: annx), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that douglas love, president and chief executive officer, will participate in a fireside chat during the 2023 cantor global healthcare conference on tuesday, september 26, 2023 at 8:10 a.m. et in nyc.
ANNX Ratings Summary
ANNX Quant Ranking